The Department of Infectious Disease is dedicated to pioneering new treatments and vaccines for various infections that face millions of people each day. We are currently enrolling patients in research studies covering the following topics:
Open to enrollment:
- Daptomycin PJI study: Treatment for osteomyelitis in a prosthetic hip or knee.
- Daptomycin bacteremia study: Treatment for MRSA bacteremia.
- Tamiflu study: Treatment for influenza in post transplant recipients.
To learn more about our research program, or to see if you qualify for enrollment, contact Pam Mason, R.N., (clinical research coordinator) at 216.445.6207 or masonp@ccf.org.
